当前位置：
X-MOL 学术
›
Mol. Ther.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Overcoming effector T cell exhaustion in ovarian cancer ascites with a novel adenovirus encoding for a MUC1 bispecific antibody engager and IL-2 cytokine
Molecular Therapy ( IF 12.1 ) Pub Date : 2024-07-19 , DOI: 10.1016/j.ymthe.2024.07.009 Saru Basnet , Mirte Van der Heijden , Dafne C.A. Quixabeira , Elise Jirovec , Susanna A.M. Grönberg-Vähä-Koskela , James H.A. Clubb , Anna Kanerva , Santeri Pakola , Lyna Haybout , Victor Arias , Otto Hemminki , Tatiana Kudling , Sadia Zafar , Victor Cervera-Carrascon , Joao M. Santos , Akseli Hemminki
中文翻译：
使用编码 MUC1 双特异性抗体接合剂和 IL-2 细胞因子的新型腺病毒克服卵巢癌腹水中的效应 T 细胞耗竭
更新日期：2024-07-19
Molecular Therapy ( IF 12.1 ) Pub Date : 2024-07-19 , DOI: 10.1016/j.ymthe.2024.07.009 Saru Basnet , Mirte Van der Heijden , Dafne C.A. Quixabeira , Elise Jirovec , Susanna A.M. Grönberg-Vähä-Koskela , James H.A. Clubb , Anna Kanerva , Santeri Pakola , Lyna Haybout , Victor Arias , Otto Hemminki , Tatiana Kudling , Sadia Zafar , Victor Cervera-Carrascon , Joao M. Santos , Akseli Hemminki
中文翻译：
使用编码 MUC1 双特异性抗体接合剂和 IL-2 细胞因子的新型腺病毒克服卵巢癌腹水中的效应 T 细胞耗竭
京公网安备 11010802027423号